Baretton, Gustavo
,
Kreipe, Hans H.
Schirmacher, Peter
Gaiser, Timo
Hofheinz, Ralf
Berghäuser, Karl-Heinz
Koch, Winfried
Künzel, Claudia
Morris, Stefanie
Rüschoff, Josef
Funding for this research was provided by:
Roche Pharma AG, Grenzach-Wyhlen, Germany (NA)
Article History
Received: 21 August 2018
Revised: 18 January 2019
Accepted: 4 February 2019
First Online: 2 March 2019
Compliance with ethical standards
:
: Experimental protocols were reviewed and approved by the local ethical committee of the principal investigator and were available for submission to the local ethical committees of the participating centers.
: GB and PS have received reimbursement and honoraria for attending symposia and advisory boards, and supplies for research from Roche Pharma AG. HK has received honoraria and reimbursement from, and acted in an advisory and/or consulting role for, Roche Pharma, Genomic Health, and AstraZeneca. TG has received honoraria for lectures and/or consultant activities from Roche. RH has received honoraria and research funding from, and acted in an advisory role for, Roche. WK is employed by BDS Koch, which receives payment from Roche for statistical services. CK is an employee of Roche Pharma AG, Germany. SM is an employee of Roche. JR has acted in an advisory and/or consulting role for Roche, MSD, and BMS, and received research funding from Roche. KB has declared no conflicts of interest.
: Qualified researchers may request access to individual patient level data through the clinical study data request platform (ExternalRef removed). Further details on Roche’s criteria for eligible studies are available here: ExternalRef removed. For further detail on Roche’s Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents, see here: ExternalRef removed.